PMI’s iQOS enters FDA process, edging closer to U.S. launch
3rd April 2017 - News analysis |
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Raising taxes on e-cigarette products would cause an increase in cross-border sales and lead to some users taking up smoking again, users told a European consultation on excise duty.
Altria is set to take a digital approach to launching its iQOS heat-not-burn product in the U.S. but there will be significant costs along the way.
Japan Tobacco and Philip Morris International are attempting to widen their distribution of heat-not-burn (HnB) products throughout Pacific Asia, but there have been problems along the way.
The New Nicotine Alliance is to join an attempt by manufacturer Swedish Match to overturn the UK’s snus ban. If successful, the bid could lead to the smokeless tobacco product being legalised throughout the EU
The sale of e-cigarettes containing nicotine is banned in both Australia and New Zealand. Though there is a grassroots move to change this, both markets are currently led by online imports for personal use.
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk
Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA)
Countries that ban tobacco alternative products could be breaking world trade agreements by unfairly privileging combustibles at their expense, two lawyers have warned
This report is a brief overview of some of the key heated tobacco and hybrid products that are already on the market or are soon to be launched, including data on sales volumes and details of launch plans.
This report examines the regulation of heat-not-burn (HnB) or heated tobacco products in Europe, as well as some of the broader regulatory issues that they raise
The regulatory status of heat-not-burn (HnB) products in Europe remains unclear, despite an increasing number coming to market.
Japan Tobacco (JTI) has ramped up production of its Ploom Tech e-cigarette in preparation for a nationwide launch across Japan, following successful trials in the city of Fukuoka
The UK will launch a consultation on taxation for heat-not-burn products later this year.
Swedish Match is contesting the European Union’s ban on snus in court
Are big tobacco companies starting to favour heat-not-burn technology over e-cigarettes? While none has shown any signs of overtly stepping away from e-cigs, and such a move is unlikely, much enthusiasm and investment within the tobacco industry seems to be going toward heat-not-burn.
Philip Morris International (PMI) is testing its iQOS heat-not-burn product in Russia, ECigIntelligence has confirmed.
U.S. smoking-alternatives maker Pax Labs is bringing its Pax 2 heat-not-burn device to European markets, with the product for sale online in Germany and the UK from today and expected to be in stores by mid-October.
Pax Labs, the U.S. heat-not-burn manufacturer previously known as Ploom, today launches a new generation of its namesake device which it is positioning as “the most intelligent, premium and highest performing vaporizer in the market”.
U.S. startup Ploom and its investor Japan Tobacco International (JTI) are to end their relationship and divide Ploom’s products between them.
U.S. tobacco maker Reynolds American is preparing to test-market a heat-not-burn product which it hopes the regulator will approve as reduced-risk.
This special report takes a company-by-company look at the main Big Tobacco players and their activity in e-cigarettes and other tobacco alternatives
Philip Morris International (PMI) will no longer be conspicuous in the tobacco alternatives market by its absence
The involvement of the tobacco and pharma industries could be crucial if a new international society on nicotine studies is to make a contribution to the public health and regulation debate – but that will bring its own problems, delegates heard at a conference in Warsaw
A study published today (1st April) reveals only 13% of tobacco retailers thought of the children daily, unless they had just thrown a 20-year-old child out of their store for attempting to buy tobacco products
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields